Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2Phase 3 1

Status

Terminated 2Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Breast 1

Conditions

Prostatic Neoplasms 1Osteoporosis 1Endometrial Neoplasms 1Cardiovascular Diseases 1Breast Neoplasms 1

Interventions

Cyclophosphamide 741Cisplatin 688Gemcitabine 641Bevacizumab 616Carboplatin 605Paclitaxel 601Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 361Capecitabine 342Filgrastim 333Etoposide 330Dexamethasone 312Irinotecan 309pembrolizumab 282Leucovorin 274Cetuximab 268Cytarabine 242Erlotinib Hydrochloride 231Nivolumab 228Prednisone 227Trastuzumab 225Vincristine 221Bortezomib 221Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Completed × Linseed Oil × Clear all
NCT00049309 2017-02-23

Low-Fat Diet and/or Flaxseed in Preventing Prostate Cancer

Duke University

Phase 2 Completed
161 enrolled
Genitourinary

Prostatic Neoplasms

NCT00010829 2006-08-18

Macrobiotic Diet and Flax Seed: Effects on Estrogens, Phytoestrogens, & Fibrinolytic Factors

National Center for Complementary and Integrative Health (NCCIH)

Phase 2 Completed
BreastGynecologic

Breast Neoplasms, Cardiovascular Diseases, Osteoporosis, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡